Morgan Stanley’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$390K Buy
31,781
+7,888
+33% +$96.8K ﹤0.01% 5576
2025
Q1
$263K Buy
+23,893
New +$263K ﹤0.01% 5621